Abstract
In the present study, the whole-cell patch-clamp technique was applied to follow the inhibitory effect of genistein — a tyrosine kinase inhibitor and a natural anticancer agent—on the activity of voltage-gated potassium channels Kv1.3 expressed in human T lymphocytes (TL). Obtained data provide evidence that genistein application in the concentration range of 1–80 μM reversibly decreased the whole-cell potassium currents in TL in a concentration-dependent manner to about 0.23 of the control value. The half-blocking concentration range of genistein was from 10 to 40 μM. The current inhibition was correlated in time with a significant decrease of the current activation rate. The steady-state activation of the currents was unchanged upon application of genistein, as was the inactivation rate. The inhibitory effect of genistein on the current amplitude and activation kinetics was voltage-independent. The current inhibition was not changed significantly in the presence of 1 mM of sodium orthovanadate, a tyrosine phosphatase inhibitor. Application of daidzein, an inactive genistein analogue, did not affect significantly either the current amplitudes or the activation kinetics. Possible mechanisms of the observed phenomena and their significance for genistein-induced inhibition of cancer cell proliferation are discussed.
Similar content being viewed by others
References
Abdul M., Hoosein N. 2002. Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett. 186:99–105
Abdul M., Santo A., Hoosein N. 2003. Activity of potassium channel-blockers in breast cancer. Anticancer Res. 23:3347–3351
Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:5592–5595
Artym W., Petty H.R. 2002. Molecular proximity of Kv1.3 voltage-gated potassium channels and ß1-integrins on the plasma membrane of melanoma cells: effects of cell adherence and channel blockers. J. Gen. Physiol. 120:29–37
Bobrowska - Hägerstrand M., Wróbel A., Rychlik B., Bartosz G., Söderstöm T., Shirataki Y., Motohashi N., Molnar J., Michalak K., Hägerstrand H. 2001. Monitoring of MRP-like Activity in Human Erythrocytes—Inhibitory Effect of Isoflavones. Blood Cells, Molecules, and Diseases 27:894–900
Cahalan M., Wulff H., Chandy K. 2001. Molecular properties and physiological roles of ion channels in the immune system. J. Clin. Immunol. 21:235–252
Cayabyab F., Schlichter L. 2002. Regulation of an ERG K+ current by Src Tyrosine kinase. J. Biol. Chem. 277:13673–13681
Chandy K., Wulff H., Beeton, Ch., Pennington M., Gutman G., Cahalan M. 2004. K+ channel as targets for specific immunomodulation. TIPS 25:280–9
Colley B., Tucker K., Fadool D. 2004. Comparison of modulation of Kv1.3 channel by two receptor tyrosine kinases in olfactory bulb neurons of rodents. Rec Channels 10:25-36
Conti M.J. 2004. Targeting K+ channels for cancer therapy. Exp. Ther. Oncol. 4:161–166
Fadool D., Holmes T., Berman K., Dagan D., Levitan I. 1997. Tyrosine phosphorylation modulates current amplitude and kinetics of a neuronal voltage-gated potassium channel. J. Neurophysiol. 78:1563–1573
Fraser S., Grimes J., Diss J., Stewart D., Dolly J., Djamgoz M. 2003. Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation. Pfuepgers Arch. 446:559–571
Grissmer S., Nguyen A., Cahalan M. 1993. Calcium-activated potassium channels in resting and activated human T lymphocytes. J. Gen. Physiol. 102:601–630
Grunnet M., Rasmussen H., Hay-Schmidt A., Klaerke D. 2003. The voltage-gated potassium channel subunit, Kv1.3, is expressed in epithelia. BBA 1616:85–94
Gulbins E., Szabo E., Baltzer K., Lang F. 1997. Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases. Proc. Natl. Acad. Sci. USA 94:7661–7666
Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. 1981. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pfluegers Arch. 39:85–100
Hirano T., Kuritani T., Kishimoto Y., Yamamura Y. 1977. T cell dependency of PWM-induced Ig production by B cells. J Jmmunol. 119:1235
Hool L., Middleton L., Harvey R. 1998. Genistein increases the sensitivity of cardiac ion channels to β-adrenergic receptor stimulation. Circ. Res. 83:33–42
Hwang T., Koeppe R., Andersen O. 2003. Genistein can modulate channel function by a phosphorylation-independent mechanism: importance of hydrophobic mismatch and bilayer mechanics. Biochemistry 42:13646–13658
Kupper J., Prinz A., Fromherz P. 2002. Recombinant Kv1.3 potassium channels stabilize tonic firing of cultured rat hippocampal neurons. Pflügers Arch. 443:541–547
Łania-Pietrzak B., Hendrich A., Żugaj J., Michalak K. 2005. Metabolic O-demethylation does not alter the influence of isoflavones on the biophysical properties of membranes and MRP1-like protein transport activity. Arch. Biochem. Biophys. 433:428–434
Mackenzie A., Chirakkal H., North A. 2003. Kv1.3 potassium channels in human alveolar macrophages. Am. J. Physiol. 285:L862–L868
Ogata R., Kitamura K., Ito Y., Nakano H. 1997. Inhibitory effect of genistein on ATP-sensitive K+ channels in rabbit portal vein smooth muscle. Br. J. Pharmacol 122:1395–1404
Panyi G., Gaspar R., Krasznai J., Ameloot M., Aszalos A., Steels P., Damjanovich S. 1996. Immunosuppressors inhibit voltage-gated potassium channels in human peripheral blood lymphocytes. Biochem. Biophys.Res. Commun. 221:254–258
Pardo L.A. 2004. Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 19:285–292
Peretz A., Sobko A., Attali B. 1999. Tyrosine kinases modulate K+ channel gating in mouse Schwann cells. J. Physiol. 519:373–384
Preußat. K., Beetz Ch., Schrey M., Kraft R., Wölfl S., Kalff R, Patt S. 2003. Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas. Neurosci. Lett. 346:33–36
Rouzaire -Dubois B., Dubois J.M. 1990. Tamoxifen blocks both proliferation and voltage-dependent K channels of neuroblastoma cells. Cell. Signal. 2:387–393
Rouzaire-Dubois B., Gerard V., Dubois J.M. 1993. Involvement of K channels in quercetin-induced inhibition of neuroblastoma cell growth. Pfluegers Arch. 423:202–205
Rybalchenko V., Prevarskaya N., Coppenolle F., Legrand G., Lemonnier L., Bourhis X., Skryma R. 2001. Verapamil inhibits proliferation of LNCaP human prostate cancer cells influencing K+ channel gating. Mol Pharmacol 59:1376–1387
Smirnov S., Aaronson P. 1995. Inhibition of vascular smooth muscle cell K+ currents by tyrosine kinase inhibitors genistein and ST 638. Circ. Res. 76:310–316
Speake T., Kibble J., Brown P. 2004. Kv1.1 and Kv1.3 channels contribute to the delayed-rectifying conductance in rat choroid plexus epithelial cells. Am. J. Physiol 286:C611–C620
Storey N.M., Gomez-Angelats M., Bortner C.D., Armstrong D.L., Cidlowski J.A. 2003. Stimulation of Kv1.3 potassium channels by death receptors during apoptosis in Jurkat T lymphocytes. J. Biol. Chem. 278:33319–33326
Su S.J., Yeh T.M., Chuang W.J., Ho Ch.L., Chang K.L., Cheng H.L., Liu H.Sh., Cheng H.L., Hsu P.Y., Chow N.H. 2005. The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochem. Pharmacol 69:307–318
Teisseyre A., Michalak K. 2004. The inhibitory effect of genistein on Kv1.3 channels in human T lymphocytes. Abstracts of the XII Conference of Polish Biophysical Society, Wrocław, Poland, 15-17 September 2004. Curr. Top. Biophys. 28:A–57
Veh R., Lichtinghagen R., Sewing S., Wunder F., Grumbach L, Pongs O. 1995. Immunohistochemical localization of five members of the Kv1 channel subunits: contrasting subcellular locations and neuron-specific co-localizations in rat brain. Eur. J. Neurosci. 7:2189–2205
Wang Z. 2004. Roles of K+ channels in regulating tumour cell proliferation and apoptosis. Pfluegers Arch. 448:274–286
Wang Y., Jia H., Walker A.M., Cukierman S. 1992. K-current mediation of prolactin-induced proliferation of malignant (Nb2) lymphocytes. J. Cell. Physiol 1532:185–189
Washizuka T., Horie M., Obayashi K., Sasayama S. 1998. Genistein inhibits slow component delayed-rectifier K currents via a tyrosine kinase-independent pathway. J. Mol. Cell. Cordial. 30:2577–2590
Xu J., Koni P., Wang P., Li G., Kaczmarek L., Wu Y., Li Y., Flavell R., Desir G. 2003. The voltage-gated potassium channel Kv1.3 regulates energy homeostasis and body weight. Hum. Mol. Genetics. 12:551–559
Xu J., Wang P., Li Y., Kaczmarek L., Wu Y., Koni P., Flavell R., Desir G. 2004 The voltage-gated potassium channel Kv1.3 regulates peripheral insulin sensitivity. Proc. Natl. Acad. Sci. USA 101:3112–3117
Yu Z., Li W., Liu F. 2004. Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells. Cancer Lett. 215:159–166
Zegarra-Moran O., Basola A., Rogolo M., Porcelli A., Rossi B., Galietta L. 1999. HIV-1 Nef expression inhibits the activity of Ca2+-dependent K+ channels involved in the control of the resting potential in CEM lymphocytes. J. Immunol. 162:5359–5366
Zhang Z., Wang Q. 2000. Modulation of a cloned human A-type voltage-gated potassium channel (hKv1.4) by the protein kinase inhibitor genistein. Pfluegers Arch. 440:784–792
Acknowledge
The authors express best thanks to our colleague from the Biophysics Department, Dr. Andrzej Poła, who kindly provided blood samples for lymphocyte isolation. This work was supported by CSR Medical University Grant No 453.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Teisseyre, A., Michalak, K. Genistein Inhibits the Activity of Kv1.3 Potassium Channels in Human T Lymphocytes. J Membrane Biol 205, 71–79 (2005). https://doi.org/10.1007/s00232-005-0764-5
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/s00232-005-0764-5